首页 › 基金 › Lynx1 Capital Management LP › CGON
Lynx1 Capital Management LP 对 CGON 的持仓历史
CG ONCOLOGY INC · 医疗保健
Lynx1 Capital Management LP 在 Q2 2026 的 13F 申报中披露持有 CGON(CG ONCOLOGY INC)31,391 股,市值约 US$2.2M,约占其申报组合的 0.26%,在其申报持仓中市值排名第 11 位。 Lynx1 Capital Management LP 最近 3 个申报季度中有 3 个季度披露了 CGON 持仓,最早可追溯至 Q4 2025。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
Lynx1 Capital Management LP 对 CGON 的持仓演变
Lynx1 Capital Management LP 于 Q4 2025 首次披露 CGON 持仓:31,591 股(约 US$1.3M)。 该持仓在 Q2 2026 达到峰值 31,391 股,市值约 US$2.2M。 在 3 次申报中,Lynx1 Capital Management LP 0 次增持、1 次减持、1 次保持不变。 最近一期申报(Q2 2026)显示持股 31,391 股、市值约 US$2.2M,环比减持 -200 股。。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2025 | 31.59K | $1.31M | 新进 |
| Q1 2026 | 31.59K | $2.14M | 持有 |
| Q2 2026 | 31.39K | $2.23M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 CGON 与 13F 数据
CGON(CG ONCOLOGY INC)属于医疗保健行业。我们追踪的基金中还有 53 只申报持有 CGON,申报仓位最大的包括:RTW INVESTMENTS, LP (US$605.0M), Decheng Capital LLC (US$452.7M), TCG Crossover Management, LLC (US$260.8M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 CGON 的基金
- RTW INVESTMENTS, LP 8.51M 股 · $604.96M · Q2 2026
- Decheng Capital LLC 6.37M 股 · $452.71M · Q2 2026
- TCG Crossover Management, LLC 3.67M 股 · $260.77M · Q2 2026
- Foresite Capital Management VI LLC 2.37M 股 · $168.36M · Q2 2026
- Seven Fleet Capital Management LP 1.89M 股 · $134.02M · Q2 2026
- DV Trading LLC 1.44M 股 · $102.27M · Q2 2026
- Avidity Partners Management LP 1.40M 股 · $99.40M · Q2 2026
- ACORN CAPITAL ADVISORS, LLC 1.13M 股 · $80.39M · Q2 2026
- Foresite Capital Management V, LLC 1.08M 股 · $76.67M · Q2 2026
- Logos Global Management LP 1.00M 股 · $71.05M · Q2 2026
- ORBIMED ADVISORS LLC 972.80K 股 · $69.12M · Q2 2026
- Jefferies Financial Group Inc. 769.95K 股 · $54.70M · Q2 2026
更多关于 Lynx1 Capital Management LP
常见问题
How long has Lynx1 Capital Management LP held CGON?
Lynx1 Capital Management LP has disclosed CGON holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is Lynx1 Capital Management LP's current position in CGON?
As of Q2 2026, Lynx1 Capital Management LP holds 31.39K shares of CGON (CG ONCOLOGY INC), valued at $2.23M, representing 0.26% of its reported portfolio and ranking #11.
Has Lynx1 Capital Management LP been buying or selling CGON?
In the latest 13F filing (Q2 2026), Lynx1 Capital Management LP reduced its position in CGON. The position peaked in Q2 2026 at 31.39K shares.
Which other funds hold CGON?
Other major institutional holders of CGON include RTW INVESTMENTS, LP, Decheng Capital LLC, TCG Crossover Management, LLC, among 53 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.